Calcium hydroxide lime - A new carbon dioxide absorbent: A rationale for judicious use of different absorbents

European Journal of Anaesthesiology

Volumn 17, Issue 10, 2000, Pages 597-600

  Baum, J ^a   Van Aken, H ^b  

^a Krankenhaus St Elisabeth Stift   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM HYDROXIDE; CARBON DIOXIDE; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; DESFLURANE; ENFLURANE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; SEVOFLURANE;

ABSORPTION; CARBON MONOXIDE INTOXICATION; CHEMICAL REACTION; DEGRADATION; FLOW KINETICS; KIDNEY FUNCTION; REVIEW;

ABSORPTION; ANESTHETICS, INHALATION; CALCIUM CHLORIDE; CALCIUM COMPOUNDS; CALCIUM HYDROXIDE; CARBON DIOXIDE; HALOTHANE; HUMANS; METHYL ETHERS; OXIDES; SODIUM HYDROXIDE;

EID: 0033790585     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.2000.00679.x     Document Type: Review

References (25)

1. The degradation, absorption, and solubility of volatile anesthetics in soda lime depend on water content
2. Carbon monoxide production from degradation of desflurane, enflurane isoflurane, halothane and sevoflurane by soda lime and baralyme
3. Carbon monoxide generation in carbon dioxide absorbents
4. Severe carbon monoxide poisoning during desflurane anesthesia
5. Dry soda lime markedly degrades sevoflurane during simulated inhalation induction
6. Die Reaktion von Sevofluran mit trockenem Atemkalk - Uberlegungen zu einem aktuellen Zwischenfall
7. Atemkalk. Hinweise zu korrektem Umgang und fachgerechter Nutzung. Stellungnahme der Kommission fur Normung und technische Sicherheit der DGAI
8. Factors affecting the concentration of compound A resulting from degradation of sevoflurane by soda lime and Baralyme(TM) in a standard anesthetic circuit
9. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme(TM) and soda lime
10. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers
11. The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A in volunteers
12. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers
13. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia
14. Effects of low-flow sevoflurane anesthesia on renal function. Comparison with high-flow sevoflurane and low-flow isoflurane anesthesia
15. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity
16. Renal toxicity of compound A plus sevoflurane compared with isoflurane in non-human primates
17. Compound A in Minimal flow sevoflurane
18. Low-flow (1I/min) sevoflurane - Is it safe?
19. Putting the brakes on anesthetic breakdown
20. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to cornpound A but does not compromise carbon dioxide absorption
21. Amsorb. A new carbon dioxide absorbent for use in anaesthetic breathing systems
22. Is lithium hydroxide an alternative carbon dioxide absorbent?
23. Low-flow anesthesia: Theory, practice, technical preconditions, advantages, and foreign gas accumulation
24. Atemkalk. Nutzungsdauer, Verbrauch und Kosten in Abhangigkeit vom Frischgasfluss